Myriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?

Insider buying vs selling

Have Myriad Genetics Inc insiders been buying or selling?
Richard Bryan RiggsbeeChief Financial Officer2023-03-0215,000$22.55
Nicole LambertChief Operating Officer2023-03-0213,184$22.74
Margaret AnconaSVP Chief of Staff2023-02-252,556$18.54
Kevin Richard HaasChief Technology Officer2023-02-251,012$18.54
Richard Bryan RiggsbeeChief Financial Officer2023-02-1811,222$19.42
Richard Bryan RiggsbeeChief Financial Officer2023-01-209,400$20.04
Richard Bryan RiggsbeeChief Financial Officer2023-01-18600$20.01
Dale MuzzeyChief Scientific Officer2023-01-01302$14.51
Nicole LambertChief Operating Officer2023-01-01853$14.51
Richard Bryan RiggsbeeChief Financial Officer2022-12-2720,000$15.15

1 of 6

MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MYGN insiders and whales buy or sell their stock.

MYGN Shareholders

What type of owners hold Myriad Genetics Inc stock?
Blackrock Inc17.67%14,356,099$331.34MInstitution
Vanguard Group Inc11.46%9,311,761$214.92MInstitution
Camber Capital Management LP8.62%7,000,000$161.56MInstitution
Wellington Management Group LLP8.36%6,787,223$156.65MInstitution
State Street Corp6.18%5,020,423$115.87MInstitution
Earnest Partners LLC4.07%3,304,456$76.27MInstitution
Glenview Capital Management LLC3.81%3,097,768$71.50MInstitution
Bank Of America Corp3.26%2,649,251$61.14MInstitution
Dimensional Fund Advisors LP3.24%2,633,864$60.79MInstitution
Disciplined Growth Investors Inc2.80%2,272,444$52.45MInstitution

1 of 3

MYGN vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MYGN92.16%7.84%Net SellingNet Selling
PACB90.94%7.17%Net SellingNet Selling
NEO70.12%29.88%Net BuyingNet Buying
RDNT58.20%41.80%Net SellingNet Selling

Myriad Genetics Stock Ownership FAQ

Who owns Myriad Genetics?

Myriad Genetics (NASDAQ: MYGN) is owned by 99.28% institutional shareholders, 8.44% Myriad Genetics insiders, and 0.00% retail investors. Paul J. Diaz is the largest individual Myriad Genetics shareholder, owning 1.28M shares representing 1.58% of the company. Paul J. Diaz's Myriad Genetics shares are currently valued at $30.50M.

If you're new to stock investing, here's how to buy Myriad Genetics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.